J. Barluenga et al.
c]quinoline derivatives. The reaction is very straightforward,
the starting materials are simple, and the products obtained
cannot be easily synthesized by other methods. The new
process supposes a one-pot three-component coupling reac-
tion between a unit of an alkynol derivative and two units
of an N-arylaldimine. Formally, the reaction could be con-
sidered a Povarov reaction in which the enol ether counter-
part is generated in situ. This strategy allows the functionali-
zation of the furan ring and leads to diastereomerically pure
furoquinoline derivatives, thereby surpassing some of the
limitations of the conventional Povarov reaction. Moreover,
the presence of a vinyl moiety in the final products would
allow further functionalization. The easy generation of mo-
lecular diversity coupled with the importance of furoquino-
line derivatives in medicinal chemistry makes the reaction
described herein an appropriate alternative for the synthesis
of potentially bioactive compounds.
Scheme 3. Mechanism of formation of furoquinolines 4.
triple bond generates 6. Protodemetallation of the latter af-
fords the enol ether 7 and releases the catalytic species.[11]
Once enol ether 7 is formed, it enters the second catalytic
cycle. Thus, the coordination of the nitrogen atom of the
imine 2 to the platinum catalyst forms 8 and favors the addi-
tion of the enol ether 7 to give the intermediate 9 through a
Mannich-type process.[12] Further reaction of the basic nitro-
gen atom with one of the acidic protons in the a-position to
the oxonium group leads to the amine derivative 10. An
elimination of aniline in 10 gives the diene intermediate 11
which reacts with the previously formed imine complex 8
through a typical Povarov process to furnish the intermedi-
ate 12.[13] Intramolecular nucleophilic addition of the elec-
tron-rich aromatic ring to the oxonium ion, followed by
rearomatization and protodemetallation leads to the final
product 4 closing the second catalytic cycle. To explain the
stereochemistry observed in products 4 we suppose that the
cyclization step in 12 occurs through a chairlike conforma-
tion in which the phenyl group occupies an equatorial posi-
tion (see 12A in Scheme 3; bold bonds were drawn to facili-
tate the visualization of the chairlike conformation).
Formation of the spirofuranquinoline 3a under acidic con-
ditions (see Table 1, entry 2), is easily understood by a
mechanism analogous to that discussed in our previous
work.[7] In a similar way, under neutral conditions, formation
of the spirofuranquinoline 3a could be explained by intra-
molecular nucleophilic addition of the aromatic ring to the
oxonium ion in 9. When an excess of imine 2 is used, and in
particular under the slow addition conditions previously de-
scribed, the concentration of imine 2 in the reaction media
is high and we suppose that the ligand-exchange reaction in
9 to form 8 and the product 10 is favored. Thus, under the
slow addition conditions, the intramolecular protonation in
9 seems to be more favored than the intramolecular nucleo-
philic addition of the aromatic ring to the oxonium ion.
In summary, we have developed a new platinum-catalyzed
Acknowledgements
We gratefully acknowledge financial support from the MEC (CTQ2007-
61048/BQU and predoctoral grant to A.M.). We also thank Dr Angel L.
Suꢁrez for his help in the X-ray structure determination.
Keywords: cyclization · domino reactions · homogeneous
catalysis · platinum · quinolines
[1] See, for example: a) K. Schiemann, S. Anzali, H. Drosdat, U. Emde,
D. Finsinger, J. Gleitz, B. Hock, H. Reubold, F. Zenke (Merck
Patent GMBH, PCT Int. Appl.), WO 2005063735, 2005; [Chem.
Abstr. 2005, 143, 133291]; b) M. Nyerges, Heterocycles 2004, 63,
1685; c) K. Hanada, K. Furuya, K. Inoguchi, M. Miyakawa, N.
Nagata (Kaken Pharma Co Ltd, PCT Int. Appl.), WO 01027086,
2001,; [Chem. Abstr. 2001, 134, 295752]; d) M. Anzini, A. Cappelli,
S. Vomero, G. Giorgi, T. Langer, M. Hamon, N. Merahi, B. M.
Emerit, A. Cagnotto, M. Skorupska, T. Mennini, J. C. Pinto, J. Med.
Augert, P. Dupassieux, P. Lenoir, M. J. Peck, D. Jasserand, J. Med.
J. D. Smith, K. Saywell, M. D. Trickelbank, J. A. Kemp, G. R. Mar-
65; g) A. Nakagawa, Y. Iwai, H. Hashimoto, N. Miyazaki, R. Oiwa,
Y. Takahashi, A. Hirano, N. Shibukawa, Y. Kojima, S. Omura, J. An-
tibiot. 1981, 34, 1408.
don in The Alkaloids, Vol. 32 (Ed.: A. Brossi), Academic Press, New
York, 1988, p. 341.
[3] See, for example: a) M. Z. Hoemann, R. L. Xie, R. F. Rossi, S.
c) L. K. Basco, S. Mitaku, A.-L. Skaltsounis, N. Ravelomanantsoa, F.
Tillequin, M. Koch, J. Le Bras, Antimicrob. Agents Chemother. 1994,
38, 1169, and references therein. See also references [1d] and [2].
[4] For leading recent references, see: a) Z. Zhang, Q. Zhang, S. Sun, T.
reaction for the diasteresoselective construction of furoACTHNUTRGNEU[GN 3,2-
10894
ꢂ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2008, 14, 10892 – 10895